No Data
No Data
US Manufacturing Index Rises To 43, Highest Since 2020
Petros Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Petros Pharmaceuticals Amends President's Employment Terms
12 Health Care Stocks Moving In Tuesday's After-Market Session
Board Reshuffle at Petros Pharmaceuticals Following Resignations
Maxim Group Maintains Petros Pharmaceuticals(PTPI.US) With Buy Rating, Announces Target Price $1
Maxim Group analyst Naz Rahman maintains $Petros Pharmaceuticals(PTPI.US)$ with a buy rating, and sets the target price at $1.According to TipRanks data, the analyst has a success rate of 27.8% and